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Abstract
Background: Vaccines potency and injection safety issues are a concern to all levels of the
service centers including the big urban center like Addis Ababa.  Therefore, knowing
contributing factors and the magnitude of the problem are imperative to improve immunization
service from the grassroots to the national levels.
Objective: The main objective of this study was to assess factors related to routine immunization
vaccines’ potency maintenance and injection safety practice in health facilities of Addis Ababa.
Methods: Data was collected using structured questioners and observation tools from 83 health
facilities, 107 health workers and 406 caretakers and analyzed using descriptive statistics and
multivariate logistics regression methods.
Result: In the finding 43% of caretakers know the kind of vaccine provided in the health facility
they visited. Seventy (65.4%) of health workers knew freeze sensitive vaccines and storage
standards. However, Vaccine Vials Monitor (VVM) was mentioned only by 18 (16.8%) of the
respondents as a temperature monitoring devices for vaccines at health facility level. About 66
(79.5%) of the health facilities achieved > 80% performance level for two third of selected
vaccine potency maintenance indicators. All immunization sites use AD syringes and about 91.2
% of the immunization sites use safety box for sharps waste disposal. Age of the health service
providers is found to be the determinant to their injection safety practices, Adjust OR [0.188
(0.052, 0.684)]
Conclusion and recommendations: The greater majority of health of service providers lack
required level of knowledge on vaccines and safe injection practices. Considerable proportion of
the study health facilities were properly mange vaccines. Age of the health service provider
found determinant factor in transforming their injection safety technique. Therefore, there need
to enhance the capacity of the health professionals through in-service training and regular
monitoring to vaccines and injection safety practices in all health facilities of Addis Ababa.
11- Introduction
Recent global estimates indicated that through vaccines three million lives are saved each year.
(1). These therefore make immunization the most cost effective public health intervention and
remain to be one of the safest health interventions. However, in spite of this positive result
immunization services has continued facing challenges which directly affects its advancements
(the coverage) and quality. Of many problems “Immunization safety” – ensuring and
monitoring the safety of all aspects of immunization, including vaccine quality, storage and
handling, vaccine administration and the disposal of sharps – is one such challenge of
immunization program (2,3). Contributing factors for these are diverse and among all service
providers knowledge and skills and care takers/parents’ awareness, trust to safety of vaccines
(attitude) and practices (bringing children to immunization sites) (4).
Moreover, failure of the integrity of cold chain, unsafe injection and injection sharps waste
disposal practices is quite common challenges and usually caused by aging equipment,
technical malfunctioning, power interruption or providers’ knowledge, skills and inadequate
supplies and improper  methods (e.g. waste disposal methods) (5, 6).
The service providers’ competency component includes knowledge on immunization and
passes the information/knowledge to parents/care takers, keeping injection equipment sterile,
correct immunization and disposal procedures (6). Operating the cold chain equipment, keep
the cold chain standard temperature, maintain appropriate stock management, understanding
and interpreting cold chain monitoring tools such us Vaccine Vial Monitor (VVM) are also
depend on the service providers’ competency (5).
2Since now, despite the advancement of injection equipment and better understanding of the
risks of cross infection and unsafe medical practices the transmission of diseases such as
human immunodeficiency virus (HIV) and hepatitis are continued through unsafe medical
practices worldwide (7).  In this regard a high prevalence of unsafe injections and their
complications has been documented throughout the world, particularly in the developing
countries, the problem is greater as more injections are given and the prevalence of blood-born
diseases is higher. Every year EPI administers over 550 million injections in developing
countries. Even though this number comprises only a fraction of all injections given, safety
must be a leading concern (6, 7).
Ethiopia introduced the Expanded Program on Immunization (EPI) in 1980, which was after
six years of the launch of WHO EPI program. Vaccines have been provided to children age
under one for the six vaccine preventable diseases namely tuberculosis, poliomalytes, tetanus,
diphtheria, pertusis, and measles (8). Ethiopia applied to  Global Alliance for
Immunization/Vaccine Fund (GAVI/VF) support for two new vaccines (vaccines against
Hepatitis B and Hemophiluse influenza type b diseases) and support was secured and the
introduction was made on 2007 (9).
Three years earlier to the new vaccines introduction application, the country have done cold
chain inventory in 2002 and the result depicted problems such as inadequate and aging cold
chain equipments at all levels, lack of cold chain equipment maintenance system and spare
parts and too many brands of cold chain equipments (10,11). Following the inventory the
country formulated and implemented the rehabilitation plan to improve the cold chain capacity
and replaced the aged cold chain equipments (11). However, monitoring reports from WHO
and UNICEF’s Supplementary Immunization Activities (SIAs) facilitators’ assessment report
3on the cold chain capacity and vaccine management indicated poor status. Health workers
knowledge and use of  VVM, vaccines handling and regular monitoring of the cold chain
temperature were reported very poor at all levels of the health system (VVM (10 Expand
program on Immune EPI).
Concerning the injection safety, Federal Ministry of Health and WHO conducted injection
safety assessment prior to the introduction of the auto disabled syringes (AD) and the result
revealed the occurrence of unsafe injection practices such us non-sterile injection and sharps
dumped in unsupervised area were observed in 30% of the health facilities visited. (11,12).
Immunization safety issues are a concern to all levels of the service centers including the big
urban center like Addis Ababa. Therefore, knowing contributing factors and the magnitude of
the problem are imperative to improve immunization service at all level.
2.2. The Rational of the study
Vaccines potency and injection safety issues are a concern to all levels of the service centers
including the big urban center like Addis Ababa. Moreover, study show that knowledge gaps
underline low compliance with vaccination coverage if safety of injection and service quality is
substandard. Child care givers are less likely to complete the immunization schedule if they are
poorly informed about the need for immunization, if not aware of the adverse event following
immunization (4, 13). Hence, identifying factors that affect immunization safety; vaccines’
potency maintenance and injection safety is imperative to design and implement effective
immunization program.
With these understanding, a cross sectional study was conducted to assess factors that related
with routine immunizations safety (vaccines’ potency maintenance and injection safety
4practices) in health facilities of Addis Ababa. The study is designed to measure the level of
care takers/parents’ awareness on immunization service, particularly the immunization safety
practices that they are utilizing in the available health facilities.
This survey was carried out from April to May, 2009 in Addis Ababa and aiming that the
outcome of the study provide information regarding the immunization safety practices of the
health facilities in the city and to be used as baseline for immunization managers and planners
in designing, implementing and monitoring vaccines potency maintenance, and injection safety
practices/.
52- Literature review
Since the launch of the Expanded Program on Immunization in 1974, vaccination programs
have been one of the world’s most cost-effective public health strategies (1,14). These
programs reduce the burden of infectious diseases globally and serve as a key building block
for health systems in the developing world (15).
Initially, immunization programs included vaccines against six diseases such as polio, measles,
neonatal tetanus, diphtheria, pertussis, and tuberculosis (1,14). The effort was continued to add
available vaccines and Global immunization partners encouraged countries to introduced new
vaccines and provides financial and technical supports. Therefore, recently, many countries
have introduced additional vaccines (for example hepatitis B, Haemophilus influenza type B,
yellow fever, conjugated pnimococcal vaccine). The introduction is done based on several
considerations like the prevalence of specific diseases, the availability of new vaccines, and
financial resources (9).
Due to the continuing concerns and interests of all stakeholders on Expanded Program on
Immunization (EPI), the programme has made remarkable success in its coverage (4).
Nevertheless of these facts, immunization service faces many challenges across the nations.
“Immunization safety”: insuring and monitoring the safety of all aspects immunization,
including vaccine quality, storage and handling, vaccine administration and the disposal of
sharps are the few (16). Moreover, system for advocacy, adverse events following
immunization (AEFI), monitoring and safety awareness activities for the public are seldom
instituted in many countries immunization program (2).
6Ensuring vaccines’ potency
Vaccines are procured from pre-qualified WHO/UNICEF or national regulatory authority
approved sources. After source approved and procured the main area to concentrate is to
maintain the required temperature both during transportation, storage, and delivery. The
standard temperature falls between + 20 to +80 Celsius for most vaccines storage at facility
level and temperature exposure should be regularly monitored (1,17). However, keeping
vaccines with this rigid standard is not possible to precisely monitor the potency of an
individual vial, thus, monitoring devises are developed to check whether the vaccine was kept
with standard temperature or not. Among many; immunization program is introduced vaccine
vial monitors (VVM), data logger which stored continues temperature readings, freeze watch
and etc. to know the level of temperature exposure while vaccines are transported or stored in
cold chain system (18,19). Moreover, shake test is done if freeze sensitive liquid vaccines are
suspected or found frozen (20).
Although, the programme is advised to keep vaccines with the aforementioned range, studies
indicated that often vaccines were found kept outside these ranges while transported and stored
in various levels of the immunization program cold stores (1, 21). The studies in developing
and developed countries indicated that, freezing occurs in the developed world was 16.7% of
the shipment, while in the developing world; the occurrence of freezing was 35% of the
shipment. The same study shows that 13.5% and 21.9% freezes during storage in the developed
and developing countries, respectively (1). In another study, frozen temperature was recorded
in 11 shipments with a minimum temperature ranging from -7.20 and -2.20 C and the number of
times that each shipment spent 00 C ranged from 2% to 50%.  In the same study, seven out of
the 11 shipments experienced heat exposure above +80 C during the monitoring period (22).
7Cold chain management study conducted in Ethiopia has also reported temperature reading
outside the standard range for vaccines storage.  In this study 64 health facilities were included
and the report showed that 33% of them failed to maintain proper temperature records, while
11.7% of them had temperature which has records outside the standard temperature range,
which is below   +20 and above +80 C (3).
Accordingly, study done in Ethiopia reported improper vaccine handling and stock
management have also equally affect the vaccines safety/ potency and increases vaccine
wastage (3, 23). The immunization safety assessments carried out in Africa exposed serious
operational problems, which are mainly linked in inaccurate estimation of needs, stock control
and distribution to next level (24, 25, 26).
Injection safety and injection waste management
Unsafe injections are directly linked to the transmission of blood borne infections including
HIV/AIDS, and the Hepatitis B and C viruses. Recent WHO estimates indicated worldwide
infections associated with unsafe injections to be: 8-16 million cases of hepatitis B, 2.4 – 4.5
million cases of hepatitis C and 80,000 – 160,000 cases of HIV infection, local reaction, sterile
abscesses which are rare (~1 per 100,000 doses), and bacterial abscess due to contamination of
vaccine or injection equipment (27,28).
Similarly unsafe injection practice in Africa, particularly in sub-Saharan Africa is also major
concern.  For example according to WHO rapport the unsafe injection practice range among
observed practice was between 20% to more than 90%, in Burkina Faso (29).
8The maim reasons behind the prevalence of unsafe medical injections in developing countries
is programmatic error which includes infection that is a result of non-sterile injection as
explained above. Likewise, the injection sharps waste management and disposal also common
risk for service providers and the community (12, 30).
The situation in Ethiopia is not that different from what is observed in many sub-Saharan
African Countries. A recent study (December 2003), in Southern Ethiopia, among 40 health
facilities (22 government, nine NGO and nine private health facilities) revealed that 74% of
178 observed injections were unsafe and 95% of the 40 health institutes lacked equipment
required for wound care or delivery. Accidental needle or sharp injury during 12 months prior
to the study period was reported by 32% of the health workers (31). Another study done in
North Wollo (September 2006) also reported 91 injections were observed, 55 (61% ) of the
injection were completed by recapping needles; of theses 30% using single hand while 69.1%
use two hand technique (32) .
Vaccine safety: Addressing Parents/Caretakers concerns
Vaccine safety is increasingly a major aspect of immunization programs and parents are
becoming more aware of safety issues relating to vaccines their child might receive (33).
Parental attitudes in this regard include health belief about the safety and efficacy of vaccine,
vaccine-preventable diseases, and the priority parents place upon giving immunization to their
children. This issue has wine the media networks interest (34). With perspectives of vaccine
safety often skewed by media reports, enquiry such as how can you practice best address
parental concern about immunization (33, 35)
9Study done in United State of America under the title “Effects of Immunization safety Concern
on immunization” reported that attitude, belief, and behaviors indicative of vaccine safety
concern contribute substantially to under immunization in the United State (36). Another study
in East Delhi, India; caretakers who were asked to list the vaccines under the routine EPI only
268 (39.3%) of caretakers could name at least three vaccines and the study indicated
understanding the caretakers level of knowledge and making caretakers more aware about
routine Immunization (37). Similar study which was done in Democratic Congo too indicated
similar findings (38).
Generally, unsafe injections are a result of multiple factors including lack of policy, knowledge
and negligence of health workers, and shortage of equipment and supplies (39). Inadequate
communications between providers with their clients regarding the immunization safety, the
injection safety precaution in particular are common problem in developing countries.
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Figure 1: Conceptual framework of the study: Links between cold chain integrity and
service providers competency with immunization safety
The above diagram illustrates the link between the cold chain integrity and providers’
competency with safe immunization practice.
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3- Objectives
3.1 General objective
The main objective of the study is to assess factors related to routine immunization vaccines’
potency maintenance and injection safety practice in health facilities of Addis Ababa.
3.2 Specific objectives
 To assess the level of parents/care takers awareness on immunization and injection
safety
 To determine the level of service providers knowledge and practices on vaccines’
potency maintenance
 To assess the proportion of health facilities which maintain vaccines with proper VVM
stages and expiry date and temperature
 To assess factors determining safe injection practices in health facilities where
immunization services are provided
12
4- Methodology
4-1 Study area
Addis Ababa is a capital city for Ethiopia and the seat of African Union. It is situated in the
heart of the country and occupies 540 square kilometer area. Administratively the city is
divided into ten sub cities and 99 keble administration.
According to the report of the 2007 population and housing census, the city has 2,738,240
population and of which 1,304,518 (48%) are male and 1,433,730 (52%) females.  The age
structure is typical to most develop world population, which is pyramid in shape. Children
under one year of age constitute 1.3 % of the total population, while those children the age of
five years   and women of child bearing age accounts for 7.2 %.  34.6% of the population,
respectively (40).
The City Administration Health Bureau is responsible for the provision of both preventive and
curative health services to the city inhabitants. There are ten sub-cities health departments
which are directly accountable to their respective sub-city administration. There are a total of
40 hospitals, 26 health centers, and 442 private clinics in the city. The distribution of the health
facilities by ownership showed that out of the 40 hospitals, five are owned by the Addis Ababa
City Administration Health Bureau, five by the Federal Ministry of Health, two by NGOs, two
by the Ministry of Defense and one by the Federal Police Commission while the remaining 25
are privately owned.  Similarly, of the 26 health centers; 24 are owned by the City
Administration and two by NGOs1. (41).
1 Among the 24 health center one is owned by the public (Kebele administration)
13
4.2 Study design
Facility based cross-sectional study design using a quantitative data collection techniques was
employed to generate information regarding the immunization safety practices of the health
facilities, service providers’ knowledge and practices of immunization and parents/care taker
level of awareness on immunization safety.
4.3 Study population
Public and private health facilities which are rendering immunization services, health workers
who provide immunization services and parents/care takers who visited the immunization
service during the survey period were included in this study.
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4.4 Sampling
4.4.1 Sample size determination and sampling procedure
Sample size for immunization sites:
All 93 immunization sites (hospitals, health centers, clinics/health stations and health posts) in
Addis Ababa were considered for the study. However, eight outreach sites which were not
operational during the data collection period and two health facilities which were closed for
maintenance were excluded and the data was collected from 83 health facilities
Figure 2: Sampling procedure
Sample Size – Service providers:
All health workers who provide immunization service in EPI room were targeted for service
providers’ knowledge and practice assessment and observation tool.   And all 107 health
workers who were found working in the health facilities EPI room were included for
interview/observation.
Addis Ababa
Private for non-
profit health sector
(NGOs)
6 HF (sites)
Private for profit
health sector
28 HF (sites)
83 Immunization sites
Public health sector
49 HF (sites)
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Sample size - Care takers/parents exist interview:
The other targets for this study were caretakers/ parents who have visited health service for
routine immunization service of their children.  Sample size for this section was determined by
using single population proportion method. The alternative estimate for unknown level of
exposure; that is 50 % exposure level for p (caretakers exposure to immunization and
immunization safety information) was considered to calculate sample size for this study group
and this yielded:-
n= Z2 pq;
d
2
Where:
p (assuming 50% of caretakers who brought their children for immunization are exposed for
immunization/injection safety information) = 50%
q is 1-p= 1-p=50
Z is confidence interval= 95%= 1.96
d is margin of error = 5%
n= (1.96)2 (0.50 * 0.50) = 384
(0.5)2
Thus: the total sample size determined were
n= 384/00.90 = 427
With 95% responses rate 406 parents/caretakers participated in this study
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Sample selection for care takers/parents exist interview
Multi stage sampling method was used to select study subject. First facilities which provide
immunization services categorized by ownership and the study samples were allocated
proportion to the 2008 EFY DPT-HepB-HIb3 administrative coverage of each facility. Further,
individual subject were selected using systematic random sampling method based on the client
load of each facility.
Figure 3: Sampling procedure (caretakers/parents interview)
4.5 Variables
Variables for descriptive analysis
o Parents/caretakers’ awareness level on immunization:
 Socio demographic factors: Age, level of education, marital status,
occupation and income
Addis Ababa
Private for non-
profit health sector
28 caretakers
Private for profit
health sector
75 caretakers
406
Parents/caretakers
Public health sector
303 care takers
17
Variables for analytical part
 Independent
o Health workers
 Age
 Sex
 Knowledge on vaccines’ potency maintenance  and immunizations
safety
 Service year in immunization unit
 levels of education/profession
 Trainings on immunization (basic and refresher trainings)
The dependant variable for this study was
 Unsafe immunization practices
4.6 Inclusion and exclusion criteria
Inclusions criteria were that parents having child age 0-12 months and agreed to participate and
who brought infant immunization card.
Children who accompanied by caretaker or parents with inadequate information on the child
previous immunization history were excluded from the study.
4.7 Data collection tools and data collection
WHO-Afro Vaccine management and injection safety assessment tools adopted and modified
for this study.  The tool was pre tested and administered to collect primary and secondary data
from study health facilities and immunization service providers.
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Data was collected during the months of April and May 2009. Thirteen data collectors who
have worked in immunization program (junior and senior nurses) were recruited and trained on
data collection tools for two days and collected quantitative data from health facilities/health
workers and parents/caretakers.  They also observe the immunization sessions, injection and
sharp waste disposal practices using structured observation checklist and made enquiry for
relevant documents, cold chain, freezing and VVM status, vaccine and injection material stock
control book, temperature records, EPI registration books.
For service providers and parents/caretakers interviews two separate interview tools were
designed in English and tested. The tool designed for caretakers is translated in to Amharic and
used to generate care takers level of awareness on immunization and immunization safety.
While the other one was used to generate information regarding knowledge and practices on
immunization safety from health workers.
4.8. Data Quality
All questionnaires were designed first in English and caretakers’ interview tool was translated
into Amharic. Prior to the data collection, all tools were pre-tested and reviewed to include the
pre-test findings. Thirteen nurse was recruited for data collection and two days training was
given on the purpose/objective of the study, ethical consideration, to be followed informed
consent and introduction to data collection tools, data quality issues and role play was done on
how to carryout interview. Data collectors were supervised by principal investigator and
trained supervisors. Completeness of field questioners were checked on the first line by
supervisors and then by principal investigator immediately on arrival and the incomplete one
were returned soon to the source for correction. Data entry was carried out by data entry clerk
and investigator and according to preceded responses entered data was checked for
completeness and accuracy.
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The possible disadvantage of collecting information that has a longer period to its occurrences
would affect the recall capacity of the respondents. To reduce the effect of recall biases data
collectors were trained to trace back important landmarks.    Furthermore, selection of the
respondents in the caretaker category where the clients were not presenting themselves for the
interview in continues bases could have faced selection bias.   To minimize this effect data
collectors were trained and instructed to wait for potential candidates to come for the interview
after determined the required sample size to each immunization sites.
The strength of the study is that data was collected from all immunization sites and service
providers, and employed logistic regression analysis to control confounding variables to
predict the association.
4.9. Data analysis
The quantitative data entered and analyzed using SPSS (statistical packages for social sciences)
version 15.0 Soft Ware and micro soft excel to summarize the data. Descriptive statistics
method used to summarize the frequencies and distribution of variables across different
categories and presented with tables, graphs and charts. The data also further analyzed and
computed for statistical association for selected variables. Odds ratio computed to test degree
of association between dependent and independent variables at 95% confidence interval and
multiple regression analysis to treat the different variable relationships.
4.10. Operational definitions
Vaccine vials with VVM at discarding points: vaccine vials with VVM reading reached 3rd
or 4th stage at any point of cold chain system is considered spoiled.
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Proper use of VVM: Use or discard vaccines according the VVM stages indicated in the
vaccine vial
Vaccine safety/potency: The ability of the vaccine to produce immune responses after
administered to recipients and be harmless to the recipient, provider and to the environment
Safe/Potent vaccine: Vaccine vial with VVM reading 1st and 2nd stage and the expiry date has
not passed  and also properly kept with continuous standard temperature in the cold chain of
the health facility  believed it’s safety ( potency) is maintained
Cold chain system integrity: cold chain system which have functional cold chain equipment
and continuous power for given period (at least the last three months)
Safe Injection: single sterile syringes and needle is used for right vaccine/medication at the
right injection site and root and disposed properly without recapping into safe container.
Immunization safety: Ensuring and monitoring the safety of all aspects of immunization,
including vaccine quality, storage and handling, the disposal of sharps and monitoring of
adverse events following immunization.
4.11. Ethical consideration
Prior to field work, ethical clearance was obtained from the joint Ethical Committee of the
University of Gondar School of Public Health and Addis Continental Institute of Public Health.
Before the actual data collection was started, concerned department in the Addis Ababa Health
Bureau were communicated through formal letter issued from Addis Continental Institute of
Public health and University of Gondar.  Official permission and supportive letter was secured
from Addis Ababa Health Bureau after the health bureau ethical committee approved the
proposal.
Informed consent which was obtained prior to individual interview; and accordingly all
respondent participated in the study based on his/her willingness.  The investigator assured that
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privacy and the confidentiality of the information given by participants in every stages of the
study by omitting names and specific identification of participating individuals and
organizations/facilities.   .
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5. Result
5.1 Caretaker Knowledge and Practice of Immunization and its Safety
5.1.1 Background characteristics of the caretakers
A total of 406 mothers/caretakers who were available on the date of the assessment in the 83
immunization sites in Addis Ababa were interviewed. The age of mothers/caretakers ranged
between 16 to 56 years with mean age of 26.6 and + 5.639 SD and median age 26 years. The
great majority, 366 (90.1%) were biological mothers to the children who were brought to
immunization session during the interview day.
Table 1: Selected socio demographic characteristics of parents/care takers participated in
study: Addis Ababa, April-May 2009
Variable
Respondents
Frequency %
Age in year = 370
< 19 24 6.5
20 to 29 259 70.0
30 to 39 77 20.8
> 40 10 2.8
Marital status n = 406
Single 51 12.6
Married 342 84.2
Widow, or separated, or divorced 13 3.2
Education = 405
Can’t read and write 35 8.6
Can read and write 18 4.4
Grad 1-6 84 20.7
Grad 7-10 125 30.9
Grad 11-12 87 21.5
College and above 56 13.8
Employment status = 406
Employed in formal or informal sectors 281 69.2
Unemployed* 122 30
Students 3 0.7
Monthly family income (in birr) = 132
<250 8 6.1
251 – 500 30 22.7
501 to 750 25 18.9
>751 69 52.3
*Unemployed includes single and unemployed mothers and those who label themselves as
housewives
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Three hundred and ninety six (96.3 %) of the respondents were female and 342 (84.2%) were
married.  A little more than two third 281 (69.2%) were employed and earn some form of
income, while 122 (30%) were unemployed. The educational level of the respondents showed
that 371 (91.4%) can read and write and 353 (87%) have formal schooling (Table 1).
5.1.2 Source of Information and Parents/caretakers’ awareness on immunization
About two third 275 (67.7%) of the respondents reported that health workers motivated them to
bring their children to vaccination posts, while 95 (23.4%) claimed that they got information
about immunization from the media. Family members, neighbors/friends, and schools were
reported as the source of information on immunization by 21 (5.2%), 12 (3%), 3 (0.7%) of the
respondents, respectively. The great majority 396 (97.5%) of the respondents believed that
vaccination prevents diseases while 86 (21.2%) and 131 (32.3%) of the respondents mentioned
that vaccination specifically prevents from measles and polio, respectively (Figure 4).
68%
23%
5% 3%
1%
Health workers
Media
Family members
Neighbors/friends
Training/school
Figure 4: Caretakers responses regarding Source of information immunization/vaccines
preventable diseases, April-May 2009, Addis Ababa.
Moreover, about 193 (47.5%) of the respondents reported that they know the kind of vaccines
provided in the study health facilities and out of them 89 (46%) mentioned only one of the
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vaccines while 122 (63.2%) listed two or more routine vaccines/vaccines preventable diseases
[of the total 25.4 % of the respondents called two of the vaccines, while 11.9% three, 8.8%
four, 8.8% five and 8.2% Six of the routine EPI vaccines]. One hundred thirty seven (77.8%)
respondents identified measles, 113 (58.5%) and 89 (46%) mentioned polio and TT vaccines
respectively (Table 2).
Table 2:  Distribution of caretakers’ responses in knowledge of vaccines provided in the
health facilities to children and vaccine preventable diseases, Addis Ababa, April-May
2009
Vaccines Parents/caretakers n=193
Yes
Number (%)
No
Number (%)
BCG 60 (31.1) 133 (68.9)
OPV 113 (58.5) 80 (41.5)
Measles 137 (70.5) 57 (29.5)
Hepatitis type B 19 (9.8) 174 (90.2)
Pertusis 45 (23.3) 149 (77.2)
Hemphilus influenza b 19 (9.8) 174 (90.2)
Tetanus toxoid 89 (46.1) 104 (53.9)
5.1.3 Parents/caretakers’ awareness on injection safety
HIV/AIDS, Hepatitis infections, injuries to the injection site and abscesses were reported as
unsafe injection outcomes by 349 (86%), 46 (11.3%), 95 (23.4%) and 18 (4.4%) of the
respondents respectively.
Eighty (19.7%) of the respondents recalled the occurrence of abscesses to their children
following immunizations and of which 13 (16.3%) respondents reported that they sought help
from health workers, while 34 (42.3%) took their children to traditional healers and 26 (32.5%)
provided care at home.
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5.2 Providers’ Knowledge, Attitude and Experience Related to Immunization and
Immunization Safety
5.2.1 Selected socio demographic characteristics of the service providers
A total of 107 health workers who have been providing immunization services in the 83 study
health facilities on the date of the assessment were interviewed and included in the analysis.
The great majority 87 (81.3%) of the respondents were female. The age distribution of this
category ranges between 20 to 60 years with mean age 33.6, median 30 years with +10.3 SD.
The majorities 62 (57%) were married (see table 3).
Table 3: Selected socio demographic characteristics of service providers: Who are
providing services in 83 public and private health facilities in Addis Ababa, April-May
2009
Variable
Respondents
Frequency %
Age in year
< 19 49 45.8
20 to 29 30 28
30 to 39 15 14
> 40 13 12.1
Marital status
Single 43 40.2
Married 62 57.9
Widow, divorced, separated 2 1.8
Education
Health assistants 6 5.6
Junior nurses 36 33.6
Senior nurses including midwives 57 53.3
Nurses with BSc. Degree 8 7.5
Ninety eight (91.6%) of all the respondents reported that they were regularly working in the
EPI units of the respective health facilities but assist other units whenever they are assigned to
do so.
The maximum service years reported by the interviewed health workers was 39 years, whereas
the services in EPI activity were 20 years. The minimum service period was seven months in
general health service and few days in immunization unit. Among the total respondents 94.4%
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were nurses and 5.6% were health assistants. Amongst all 59 (55.1%) of the respondents
reported that they have taken in-service training on immunization and related issues. Out of
those who reported taking such training 15 (25.4%) mentioned taking mid level EPI managers
(MLM) training 22 (37.3%), Immunization in practice (IIP) training, 29 (49.1%) injection
safety and 22 (37.3%) were trained on cold chain management. Thirty three (55.9 %) of these
who have had basic training also reported that they have taken refresher training on the above
mentioned trainings.
5.2.2 Injection safety knowledge and practices
All the interviewed health workers reported that they started administering injection to
clients/patient soon after they graduated from the pre-service training schools
Assessment   made on the respondents’ awareness about the possible outcomes of unsafe
immunization practice showed that about 66 (61.7%) respondents mentioned HIV/AIDS, 47
(43.9%) hepatitis B and C and 43 (40.2%) exposure to injury and 35 (32.7%) abscess. About
97 (90.6%) of respondents in this category (service providers) were mentioned at least one of
the above risks as the unsafe injection practices. Of which only 3 (3.1%) respondents called all
of the above risks of unsafe injection practices.
A little more than a third 41 (38.3%) of the respondents believed that all immunization
activities taking place in their respective health facilities safe and exposure to problems related
to unsafe injection practice is unlikely to occur in their health facilities. While, 31 (29%) of the
respondents reported that they have come across unsafe injection practices during their career.
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Use of single sterile syringe and needle 87 (81.3%), proper sharp waste collection and disposal
were the  measures mentioned by the respondents to avoid unsafe injection practices and
prevent the public, patient and health workers [no recapping] from infection and accidents.
5.2.3 Service providers’ knowledge on vaccine safety maintenance and practices
Queries made on the respondents knowledge on vaccine safety showed that 93 (87%) of the
health workers who participated in the survey knew the standard temperature for vaccine
storage at heath facility level and 83 (77.6) of them reported that they checked the refrigerator
temperature status twice daily. Moreover, 73 (68.2%) of the respondents were able to correctly
describe the actions required to ensure vaccine potency at the time of power interruption.
Seventy nine (73.8%) of the respondents correctly identified vaccines which need shake test
when exposed to freezing and 70 (65.4%) knew freeze sensitive vaccines and storage
standards. Dial thermometer is known temperatures monitoring devises by the majority of the
health workers as mentioned by 73 (68.2%) of the respondents.  Freeze watch is also
mentioned as a common temperature monitoring device in health facility cold-chain system.
However, Vaccine Vials Monitor (VVM) was mentioned only by 18 (16.8%) of the
respondents as a temperature monitoring devices for vaccines at health facility level.   Seventy
six  (71%) of the respondents also well described the correct actions when the VVM is
changing to the discarding points and mentioned the importance to monitor vaccine potency
using VVM  when the vaccine is put outside the cold chain.
The health workers knowledge on multi dose open/liquid vaccines policy (MDVP) showed that
54 (50.5%) of the respondents described the key points in the MDV policy correctly. However,
among all including those who have sufficiently described the MDVP, 42 (39.3%)  wrongly
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interpreted MDVP and mentioned reconstituted measles vaccines to be treated as  a liquid
vaccine and should be kept until its VVM is changed to discarding point or expired or finished.
Regarding the actions required on the management of reconstituted vaccines, 84 (78.5%) of the
respondents indicated the correct discarding time after the vaccines reconstituted.  While,
twenty three (21.5%) of the respondents believed that the reconstituted vaccines could be kept
in the cold chain until finished or VVM changed (Table 4).
Only 16 (17.48%) of interviewed health workers declared that they have the copy of injection
safety and sharp waste disposal guideline which was provided in 2004 by FMOH. But the rest
95 (89.2%) do not know the existence or reported never received such documents.
Sixteen (19.2%) of the interviewed health workers reported that they had accidental needle-
sticks injury while providing injection during the last 12 months.
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Table 4:  Providers’ knowledge on vaccines potency maintenance and vaccines wastage
monitoring. April-May 2009
Descriptions Frequency
Yes
Number (%)
NO
Number (%)
Health workers know the required standard
Temperature to store vaccines at the service level (2-
80 C temperature level) n=107
93 (86.9) 14 (13.1)
Health workers well described the steps of shake
tests
n = 107
43 (40.2) 64 (59.8)
Health workers know what to do in case of cold
chain failure n= 107
66  (61.7) 41 (38.3)
Health workers know the different stages of  VVM
= 107
74 (69.2) 33 (30.8)
Health workers well described the MDV policy for
liquid vaccines  n= 83
54 (65.1) 29 (34.9)
Health workers know how to calculate the  wastage
rate n= 83
44 (53) 39 (47.0)
5.3 Immunization and related practices in the visited health facilities
5.3.1 Characteristics of health facilities included in the study
The ninety three immunization service centers in Addis Ababa city administration (static
immunization sites) were targeted for this study and data was collected from 83 of them.
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Table 5: Profile of the study sites (immunization sites) 83 public and private health
facilities in Addis Ababa, April-May 2009
Descriptions Number %
Public owned 49 59.0
Health Centers 28 33.7
Health Stations 7 8.4
Health Posts 11 13.3
Hospitals 3 3.6
Private 28 33.7
Hospitals 15 18.1
Clinics 13 15.7
NGOs 6 7.2
Total 83 100
Of the 83 health facilities 49 (59%) were public owned and 28 (33.7%) owned by the private
sector and six (7.2%) by private for non profit (NGOs clinics).
5.3.2 Observation of the actual immunization practices by the health workers
Eighty three health workers working in 83 of the health facilities were observed while
performing vaccination activities.  Fifty nine (71.1%) of the observed health workers were
observed while using clean designated tables to prepare vaccines for vaccination session, while
24 (28.9%) of the health workers were observed conducting the session in crowded tables. In
all the observed vaccination sites Auto Disabled (AD) syringes and needles from the sterile
packs were used, however, 20 (24.4%) of the health workers were observed keeping needles in
vaccines vials between injection or until the content of the vial is finished.  In 71 (85.5%) of
the observed facilities health workers disposed used syringes and needles immediately after use
in a puncture-proof safety boxes. While in 20.5% of the observed immunization sites health
workers were collecting used syringes and sharps in plastic containers like plastic buckets and
used medical containers. About 12 (14.5%) of the health workers were also observed practicing
two hands recapping after injections.
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In all the observed immunization sites freeze dried vaccines reconstituted with correct volume
diluents of the same manufacturer products. Among all study facilities 59 (71%) health
workers observed when preparing reconstituted vaccines for use. Of all 41 (69.5%) of the
health workers kept/used clean barrier (e.g. cotton or small gauze pad) to protect fingers when
breaking the top of glass ampoules (BCG vaccine), while 18 (30.5%) of them were observed
cutting the ampoules without barriers.
5.3.3 The cold chain system in the visited health facilities
Eighty one (97.6%) of the study facilities is found to have functional cold chain
equipment/system. In sixty eight (81.9%) of the facilities vaccines were properly stored, while
in 15 (18.1%) of the facilities vaccines were stored in inappropriate manner (freeze sensitive
vaccines put near to freezer, twice daily temperature records not well implemented etc). In
eighty one (97.6%) vaccination sites sufficient ice packs/cold water bags and vaccine carriers
were observed.
The observed daily vaccine temperature monitoring sheets showed that in 81 (97.6%) of the
health facilities cold chain temperature was monitored twice per day. However, when the last
three months data was reviewed, it was found out that in 12 (14.5%) of the health facilities
temperature monitoring and recording activities were interrupted, in the 17 (21.5%) health
facilities the cold chain temperature records were found below 2 degree centigrade, and in 19%
of the health facilities temperature recorded were greater than eight degree centigrade. The
number of days that the temperature readings outside the standard range were between 1 and10
days in the above mentioned facilities.
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All facilities reported electric power interruptions in the last six months and 39 immunization
sites i.e. 47% of the immunization sites reported that they used back-up generator when power
supply interruption occurs.
Table 6: Distribution of health facilities holding/managing vaccines properly by level and
ownership, in 83 public and private health facilities in Addis Ababa, April-May 2009
Facilities level and
ownership
vaccine kept safe in
the health facilities
Total
Yes No
Public owned 43 6 49
Health Center 24 4 28
Health Station 7 0 7
Health post 9 2 11
Hospital public 3 0 3
Private 21 7 28
Hospitals 13 2 15
Clinics 8 5 13
NGO clinics 4 2 6
Total 68 15 83
5.3.4 Vaccine Management in the Health Facilities
Eighty 80 (96.4%) of the health facilities reported that all freeze dried vaccines are always
ordered and received with their diluents and kept with two to eight degree centigrade
temperature before use.
In about 76 (91.6%) of the visited cold chain sites (health facilities) the Vaccines Vial Monitor
status was found in a good stage(VVM stage 1 and 2), while in 6 i.e. 7.2% sites  VVM stage 3
and 4 were observed indicating VVM reached to the recommended discarding point.  The
observations made on the availability of spoiled vaccines in the health facilities cold chain
system further showed the existence of 24 vials of measles and 5 vials OPV with VVM stages
3 and 4 in two different health facilities, while a total of 135 doses of pentavalent vaccines with
the same stage of VVM (stage 3 and 4) were found in other five different health facilities.
Further in these regard vaccines which have passed expiry date found in 9 (10.2%) of the
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health facility (see table 7). The number of vaccines which have passed expiry date were 142
(BCG 16, OPV 20, , Measles 16, Tetanus Toxoid 16 and 72 Penatvalent vaccine vials).
In line with the MDV policy, in sixty five (78.5%) of the health facilities an opened vials of the
liquid vaccine were found kept for next immunization sessions. Similarly 71 (85.5%) of the
health facilities were found discarding reconstituted freeze-dried vaccines at the end of the
session (if the session end before six hours) or after six hours of opening/reconstituting the
vaccine. However, about 9 (10.8 %) of the facilities were found reserving opened vials of
freeze-dried vaccines for next sessions in their cold chain (see table 7).
Further assessment made on vaccine management issue showed evidences of vaccine wastage
monitoring activities like computing the number of open vaccine vials against number of
children received vaccination to estimate wastage rate,  in 49 (59%) health facilities and 43
(51.8%) of the service providers know how to calculate wastage rate. However, only 29
(59.2%) of the 49 facilities were used the vaccine wastage monitoring document to minimize
vaccine wastage rate.
Table 7: Vaccine management practices, vaccine potency maintenance and Injection
safety practices in 83 public and private health facilities in Addis Ababa, April-May 2009
Descriptions
Immunization Sites
Yes No
Presence of vaccines stock record book/sheet for vaccines,
diluents and dropper in the health facilities n= 82
78 (94%) 4 (4.8%)
Facilities its’ Stock book/sheet updated every time n=82 66 (79.5%) 12 (14.5%)
Facilities which hold sufficient vaccine stocks and diluents until
the next sessions n=83
72 (86.7%) 11 (13.2%)
Presence of record for vaccine wastage for all antigens  n= 83 49 (59%) 34 (41%)
Presence of vaccines which its VVM reached discarding points
(vaccines with VVM stage 3 and 4) n= 82
6 (7.2%) 76 (91.6%)
Presence of vaccines which its expiry date already passed n=83 9 (10.2%) 74 (89.2%)
Presence of frozen vaccines in cold chain system n=72 4 (4.9 %) 68 (82.9%)
Presence of freeze dried vaccines in the refrigerators after
reconstitutions for next immunization sessions n= 83
3 (3. 6%) 80 (96.4%)
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The World Health Organization standard/ the cut of points for vaccine management and the
integrity of cold chain for selected indictors sated to be about 80% and above in all levels of
cold chain system. This indicator includes; the reliability and flexibility of cold chain, VVM
and MDV policy use, stock control, vaccines availability etc.
Accordingly this study finding was entered into the WHO Vaccine management (VAM) tool
and analyzed. In the finding about 66 of the health facilities achieved > 80% performance level
for two third of the selected indicators. Of all selected indicators availability of vaccines,
adherences with MDV policy, proper use of VVM and diluents were about 80 % and above.
Nonetheless, stock control and vaccine wastage management achieved less than 80%
performance rate (vaccine wastage control < 60% and stock control between 70 to 80%).
Figure 5: Vaccine management performance of the study health facilities, Addis Ababa,
20092Key: 1 unit in the spider web is equivalent 20% vaccine management practice of the study
2 The data entry sheet and spider wave template is adopted form WHO VAM tool module
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5.3.5 Injection safety and sharp waste management
All visited immunization sites are found using Auto Disables (AD) syringes for immunization
and all keep sufficient quantity of 0.5 ml AD syringes compared to the client load of the
individual immunization sites’. However, 49 (59%) of the health facilities are found to have
less than 10 pieces of  AD syringes for BCG in their stock indicating  a possible stock out if
not supplied on time.  Similarly of the 83 visited health facilities   74 (89%) and 62 (74.7%) of
them were found to have less than 10 pieces of the 2 and 5 ml syringes which are required for
reconstituting freeze dried vaccines. Despite these findings, 80.7% and 79.5% of the health
facilities reported that they never faced stock out of AD syringes puncture proof safety box
respectively within 12 months period from the survey date. In 13 (15.7%) immunization sites
clients are required to buy or bring syringes and needles to be used for reconstituting freeze
dried vaccines.   About 69 (83.1)% and 64 (77.1%) of the visited immunization sites reported
that the injection material and safety boxes received from the regional health bureau and sub
city administration health office always match with quantity of vaccines respectively.
Assessment made on the available waste disposal facilities showed that, at the time of survey
puncture proof safety boxes were available in 76 (91.2%) immunization sites. Fifty seven
facilities (73%) use incinerator, 9 (12%) open burning on the ground, 5 (6%) use open burning
hole, 5 (6%) transport for offsite disposal and 2 (3%) dumping in secured pit. In 14 (16.9%) of
the immunization sites there observed sharps around the disposal sites (Figure 6).
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Figure 6:  Distribution of medical sharps waste disposal methods in the study facilities,
April-May 2009, Addis Ababa
The greater majority in both public and private owned health facilities use incinerator for
medical waste disposal (Figure 7).
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Figure 7: Distribution of medical sharps waste disposal by facility ownership. April-May
2009, Addis Ababa
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Table 8: Socio demographic characteristics of immunization service providers and
injection safety practices: Addis Ababa, April-May 2009
Descriptions
Observed Safe
injection Practices
Crude OR
(95% CI)
Adjusted OR
(95% CI)
No Yes
N % N %
Y
(Observed
safe
injection
practices)
Age
< 30 years 6 14.3 36 85.7 1.00
> 31 years 15 36.6 26 63.4 0.289 (0.099,0.845) 0.188 (0.052,0.684)
Education
Health assistants 1 16.7 5 83.3
Junior nurses 5 14.7 29 85.3 1.160 (0.111,12.132) 1.055 (0.086,12.984)
Senior nurses
including B.Sc
15 34.9 28 65.1 0.373 (0.040,3.495) 0.241(0.24,2.425)
In service
training
No 7 28 18 72 1.00
Yes 14 24.1 44 75.9 1.222 (0.423,3.528) 1.302(0.399,4.253)
Service Year
< 2 years 4 26.7 11 73.3 1.00
> 2  years 17 25 51 75 1.091 (0.307,3.881) 4.489 (0.788,25.593)
Age (X1) of the service provider has shown relationship with adherence of safe injection
practice (Y) when the result was computed with univariable and multivariate logistics
regressions (Table 8). The result has shown significant association between the age of the
respondents and the observed safe injection practice with Crude OR 0.289 (0.099, 0.845) and
Adjusted OR 0.188 (0.052, 0.684).
38
Table 9: Observed safe immunization injection practices in study facilities. Addis Ababa,
April-May 2009
Descriptions Frequency
Yes (%) NO (%)
For each injection use syringes from serial packs (AD or disposable
syringes)   n=79
77 (97.5) 2 (2.5)*
Removal of all needles from vaccines vials between injections n =77 57 (69.5) 20 (24.4) **
Use of clean barrier (e.g.) small gauze pad) to protect fingers when
breaking the top from the glass ampoules n= 69
41 ( 59.4 ) 28 (40.6)
Health workers avoiding two hands recapping of needles after
injection  n= 83
71 (85.5) 12 (14.5)
Used syringes (AD and disposable) collected in a punctured proof
safety containers immediately after the injections. N=78
64 (77.1) 14 (16.9)
Health workers reported accidental needle stick injury during the
last 12 months=83
16 (19.3) 67 (80.7)
* Syringes and needles where taken out from their packs ahead
** Needle left in reconstituted measles vials to draw vaccines
Almost in all observed health facilities (97.5%) syringes and needle were used from serial
packets while in 2 facilities (2.5%) health workers were takeout the AD syringes from the
sterile packs prior to the child arrival in the injection table. In each injection health workers in
57 (69.5%) of the health observed health facilities were removed the needles from the opened
vials for each injection but 20 (24.4%) were keeps one needle in the vial until its contents
(vaccines) is finished (Table 9).
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6. Discussions
The study finding suggested that the vaccines potency maintenance and management practice
in the assessed health facilities is improving in some area such as cold chin integrity
(availability of functional and flexible cold chain system), vaccines availability, diluents use,
distribution efficiency are improved when compared to the 2002 WHO vaccine assessment
report which was less than 50% for most of the indicators for e.g. the cold chain integrity and
vaccine management (32).
In addition, the logistic regressions analysis results depicted that the transformation of the
injection safety practice depend on the age of the health providers, Adjusted OR with 95% CI
[0.188 (0.052, 0.684)] (Table 8). The younger the age of the service provider the better the
compliance/adhere to desirable injection safety procedures. Study done in Jingzhou district,
Hubei, China regarding injection practice revealed that the younger the medical worker, the
better his / her knowledge of safe injections, which could be because the youngsters had more
chances for studying, better memory and greater interest in acquiring new knowledge
(Adjusted OR with 95% CI [0.099 (0.017,0.574) and 0.105 (0.021,0.517)] (40).
6.1 Parents/care takers awareness on immunization and immunization safety
The parents/care takers’ level of awareness regarding vaccines, its benefits and injection safety
showed that only 43% of the care takers know some of the routine vaccines that are provided in
the health facilities (Table 2). However, except few almost all were not able to mention the
eight antigens provided to children as part of the routine immunization services in the health
facilities in the country. The community based cross-sectional study done in East Delhi in 2006
reported that  when mothers asked to name the four disease covered under routine EPI
program; only 268 (39.3%) could name at least three (37). Similar study done in Democratic
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Republic of the Congo has also indicated 3% of mothers could be able to call some of the EPI-
targeted diseases. In this study although, the majority of the caretakers did not know the kind
of vaccines that their children have taken, 97.5% of parents/care believed that vaccines can
prevent diseases and this result is almost similar with the DRC study report that was 98% (38).
Result of the enquiry forwarded to caretakers regarding communication and source of
information on immunization and related issues revealed that health workers (67.7%) and the
media (23.4%) were reported as the main sources of immunization information to caretakers
(Figure 4). However, study done in Democratic Republic of the Congo (DRC) during 1999s
indicated a higher proportion of caretakers to both sources; 82.3 % and 54.3% health facilities
and radio (media), respectively (38).
6.2 Service providers’ knowledge and practice
Only about 55.1% and 43% of the interviewed health workers, who were found, providing
immunization, reported receiving in-service training on immunization and injection safety
respectively. This finding is almost similar to what was found in a study conducted in North
Wollo Zone, Amhara region where only 45.8% health workers have had exposure to any
infection prevention training (32). Other studies conducted elsewhere in Africa have also
documented problems related with in-service trainings, refresher training and its impact on
immunization services (4, 25, 26).
Unlike the findings of the study conducted by Mesele, in North Wollo where 99.4%, 54.7%, 79
% mentioned HIV, Hepatitis B and hepatitis C as a possible consequence of using dirty needles
and sharp material, the outcome of this study showed that low proportion of health workers i.e.
71% and 43.9% mentioned HIV/AIDS, Hepatitis B and C as possible consequences of unsafe
injection practices.
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In this study respondent’s knowledge on vaccines potency maintenance   were found to be
diverse. About 73.8 % correctly identified vaccines which needs shake test when exposed to
freezing, 40.3 % described the shake test procedure and more than two third know the
temperature monitoring devises (Table 4). This study results are better as compared to the
study done in Mozambique in cold chain management which was reported that 67 % health
workers know the freeze sensitive vaccines while the 52% respondents know recommended
temperature but only 4 respondents were know shake test (5). Knowledge regarding VVM was
also correctly described by 71% of the respondents. However, about one third of the service
providers are found lacking these essential skills which are the key to effectively manage the
vaccines and maintain vaccines potency. This result was similar with the study done in 2007 in
Uganda by WHO. The Uganda study result reported on the knowledge and effective use of
VVM was 72% (26).
Knowing and complying with guidelines and policies are known to have an effect on safe
immunization practices.  In this study knowledge and practice of the health workers about
policies and procedures were low. Where only 65 % of the health workers were able to
correctly describe the MDV policy (Table 4). This finding is low compared to that of the
Namibia and Uganda studies (79% and 86%, respondents correctly described the MDV Policy
in the Namibia and Uganda VMA study) (25, 26). And about 39.3% of the respondents
including those who correctly described the MDV policy have misunderstood as the
reconstituted freeze dried vaccines to be handled or kept beyond six hours as liquid multi dose
vaccines.  The consequences of such miss understanding have been observed practically where
in 10.8% of the facilities reconstituted measles vaccines were kept for the next sessions.
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The structured observation result exhibited unsafe practices which could expose service
providers and clients to risks of possible infection. Practices such as recapping with two hands
after providing injection and, leaving needles in vaccines vials, improper disposal of medical
sharps indicated risk of health hazards due to injection practices. Similarly study done in
Tigray, Amhar and Dire Dawa reported very serious and major shortcoming and could be
dangerous practices in the area of injection administration (31).
6.3 Cold chain integrity and vaccine management
In this study about 97.6% of the health facilities are found to have functional cold chain
equipment. However, only in 81.9% of these facilities vaccine storages were found to be
proper. Similar proportion (80%) on proper vaccine storage was reported by the different
studies conducted in Namibia and Uganda (25, 26).
Findings of the study regarding updating the vaccines stock record book, vaccines wastage control
system and making use of the available information to reduce wastage showed varied results. In
this regard, 94% of health facilities have stock record books but 79.5% have updated the records
and only 51% make use the records to reduce the wastage. The result revealed better position when
compared to the assessment done in 2002 in Ethiopia and 2008 Uganda and Namibia (the VAM
result was < 50% performance level) (23,25,26).
6.4. Injection safety practices
Compared to the client load they have all visited immunization sites keep sufficient quantity of
0.5 ml AD syringes. Moreover, about 80.7% and 79.5% of the visited health facilities reported
never faced stock out of AD syringes and puncture proof safety box respectively, within 12
months period from the survey date. This could be mainly due to the proximity of the health
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facilities to the regional and sub city stores where the health facility could collect the required
supply when needing to replenish the stock.
In this study the waste disposal practices of the visited health facilities showed that, puncture
proof safety boxes were available in 91.2% of the sites. Other proper waste disposal facilities
like incinerators, protected burning pit and the practice of dumping in secured pit were found
in 68.7% 6% and 2.4% of the facilities respectively. While in 14 i.e. 16.9% of the visited health
facilities sharps objects are found around the disposal sites. These results are much better
compared the studies done by FMOH and WHO in 2000. The FMOH/WHO study reported that
only in 11% of the health facilities that were found punctured proof safety boxes and reported
that in nearly 50% of the study facilities there was evidence of sharps around the health
facilities (12). Another study done in 2006 in North Wollo also reported that only 73.8% of the
observed health facilities had puncture proofed safety boxes for used injection sharps (32).
Only few (16.2%) were reported that they have or seen the National Injection safety guideline.
About 14.5% of injections were last with two hands needle recapping and 19.2% health
workers reported that they had accidental needle stick during the last 12 months (Table 9).
This result however is small as compared to the studies done in Burkina Faso and North Wollo.
About 61% recapping reported in North Wollo and 61% needle stick occurrence reported from
Burkina Faso studies (29,32). These therefore, suggested injection practice seemed improved
when compared to the 2000 FMOH and WHO study report (12).
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7. Conclusion
For the majority of caretakers, service providers are the major sources of information on
immunization
The greater majority of service providers do not have the required level of knowledge on
vaccines’ potency maintenance and safe injection practices
Considerable proportion of the study health facilities properly mange vaccines and
injection materials
The transformation of injection safety knowledge of the health service providers is found to
be the determinant to their injection safety practices.
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8. Recommendations
Improving vaccines potency and injection safety practices required orchestrated effort of the
stakeholders such as caretakers, service providers, programme managers, the media and
partners including donors at all levels. To effect the desired goal which is providing potent
vaccines and safe injection the following recommendations are forwarded to Addis Ababa City
Administration Health Bureau, Sub Cities Health  Departments, health facilities and partners
who have direct involvement in child survival activities/immunization.
The Addis Ababa Regional Health Office, Sub City Health Departments and the
respective health facilities should:
 Enhance the capacity of the health professionals through in-service training and regular
monitoring to provide comprehensive immunization/ vaccination related information to
caretakers.
 Carryout capacity assessment of the health workers and organize regular/periodic
refresher trainings to fill the competency gaps in vaccines potency maintenance and
safe injection practices
 Make available back-up generators if incase power is fails beyond the cold chain
capacities (if it is beyond the cold box, vaccine carriers and other measures capacity)
 Make available documents such as EPI and injection safety and medical waste
management policy and guideline,
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List of Annexes
Data Collection Tools
1.0. Questionnaires
Routine immunization vaccines safety assessment study in health facilities of Addis Ababa
Facility Level
Questioner Identification:
001 Sub-city --------------------------- 002 Health facility name ---------------------------------
003 Cluster No ------------------------- 004 Record Number -------------------------------------
005 Name of Interviewer -------------------006Date of interview __/___/___signature _________
007 Name of Supervisor ---------------008 Date of supervision __/___/___signature _____
Introduction and Consent
Verbal consent form
Good morning/afternoon. My name is ________________________________________.
Thank you for taking the time to talk with me. I came from Addis Continental Institute of Public
Health, a higher institution conducting Joint Master of Public Health (MPH) program with the
University of Gondar. We are asking questions of care takers/parents such as you, throughout Addis
Ababa, and collecting data for a master's thesis named “Routine immunization vaccines’ potency and
injection safety assessment study in health facilities of Addis Ababa". This health center has been
chosen to be included in the study. If you agree to be interviewed, I will be asking you questions about
immunization practices: vaccines potency and injection safety practices. We are interested in finding
out how vaccines and injection safety practices are maintained. This information will be used to help
quality immunization services for children in Addis Ababa.
If you decide that you do not want to participate in the study, or decide at any time in the future that you
do not want to participate, it will not affect the services you provide at the health center now or in the
future. While the results of this study may be published, your privacy will be protected and you will not
be identified in any way. No one, including your supervisor provider, will know your answers.
Your opinions and experiences are important to us, so please be honest and truthful in answering our
questions. Your answers will be confidential and secret. If you agree to be interviewed, we will go to a
place where no one can hear us talking. If you are uncomfortable with a question, you do not have to
answer it if you do not want. You may also stop the interview at any time.
It will take about 20-30 minutes for us to complete the questionnaire. Do you have any questions about
the study? If you have any questions about the study in the future, please feel free to contact University
of Gondar, Addis Continental Institute of Public Health and Addis Ababa Health Bureau.
__________________________________         ____________
Signature of person administering consent            Date
If client refuses to be interviewed, please check this box:
Time interview began: _____:   ______
Hours    Minutes
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Section one: Background
No. Question & filters Coding categories Skip to
101 Record sex of the respondent Male
Female
1
2
102 Record the age of the respondent _______
103 How many years you are in health
service
Service in complete year _______
104 How many years you are in
immunization service
Service in complete year _______
105 What is the highest level of
schooling (profession)
Health assistant _______
Junior nurse __________
Senior Nurse _________
B.Sc in nursing/public health ___
Other
1
2
3
4
5
106 Did you attend training on
immunization
Yes _____
No ______
1
2
If no
skip to
107
107 When was the last training you have
taken
_______________
108 If yes, which training did you take? MLM training ______
IIP training _________
Immunization safety _______
Cold chain users _______
Other (describe) ________
1
2
3
4
5
109 Have you taken  refresher training on
immunization
Yes __________
No ___________
1
2
If no
skip to
201
110 If yes which of these trainings have
you taken
MLM training ______
IIP training _________
Immunization safety _______
Cold chain users _______
Other (describe) ________
1
2
3
4
5
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No. Question/Observation & filters Coding
Category
Current status/Findings
(observation findings)
Skip to
200 Flexible cold chain exist for all vaccines
201 Is there functional cold chain equipment for
storing vaccine?
Yes
No
1
2
202 Is the vaccine storage in the cold chain properly
done? (i.e. no vial in the door, no vial without
label, no TT and  DPT-HepB-Hib vaccines freeze
and, no drink or food, no other medication)
Yes
No
1
2
If no
skip to
205
203 Are there frozen vaccines Yes
No
1
2
204 If yes list the quantity in the space provided DPT-HepB-Hib _____
TT _______________
205 Do the health workers know and follow the
correct procedures for vaccine transport? (ask for
the procedure)
Yes
No
1
2
206 Do the health worker know correctly describes
the shake test (when and how shake test is done)
Yes
No
1
2
300 Adequate quantity of vaccines are always available
301 Is the stock of vaccine sufficient until next
supply arrivals? (i.e. stock sufficient for one
month or two weeks )
Yes
No
1
2
302 Has sufficient stock of all vaccines and diluents
always been available during the last three
months?
Yes
No
1
2
303 List quantity of the available vaccines in the
space provided
BCG _____________
OPV _____________
Measles ___________
DPT-HepB_________
TT _______________
400 A satisfactory stock recording system exists for all vaccine, diluent and droppers
401 Do the stock record books/ sheets exist for
vaccines, diluent and droppers?
Yes
No
1
2
402 Is lot/batch numbers and expiry dates recorded? Yes
No
1
2
403 List quantity of vaccine/s if there is any that its
expiry date has already passed
BCG______OPV ______
Measles ______
DPT-HepB-Hib _____
TT ______________
404 Is the stock book/sheets updated every day/every
time? (when vaccine withdraw or added in the
cold store)
Yes
No
1
2
500 An efficient vaccine distribution system ensure continuous and adequate vaccine at lower level
501 Is vaccine utilization made according to “first in-
first out” principle?
Yes
No
1
2
502 Can the health workers make exemptions to this
rule? e.g. VVM status and expiry date
Yes
No
1
2
503 Are vaccine order/receipt forms used (check
completeness and records quality)?
Yes
No
1
2
No. Question/Observation & filters Coding
Category
Current status/Findings
(observation findings)
Skip
to
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600 Reliability cold chain exists for vaccine storage  (cold chain integrity)
601 Is cold chain temperature monitored and
recorded at least twice per day?
Yes
No
1
2
602 Has the temperature been maintained at
correct level during the last 3 months
Yes
No
1
2
603 Record number of days that the temperature
reading outside the standard rage  in the last
three months
< 2 c0 for ______ days
> 8 c0 for ______ days
604 Are there sufficient cooled/chilled water
bags?
Yes
No
1
2
605 Are there sufficient vaccine carriers? Yes
No
1
2
606 Is there continuous power supply? Yes
No
1
2
607 Have vaccine been kept safe in the cold
chain during the last six months?
Yes
No
1
2
608 Do the heath workers know what to do in
case of cold chain failure?
Yes
No
1
2
700 Proper diluent used for frizzed –dried vaccines
701 Are all freeze-dried vaccines always
ordered/ received with their diluents?
Yes
No
1
2
702 Does stock of diluents correspond to the
stock of freeze-dried vaccines?
Yes
No
1
2
703 Do health works use the correct diluent with
each freeze-dried vaccine?
Yes
No
1
2
704 Have diluent been used at the correct
temperature for immunizations? (cooled to 2
to 80 C prior to use)
Yes
No
1
2
800 Vaccine Vials Monitor (VVMs) effectively used for vaccine management
801 Are all VVMs on the vaccines vials good? Yes
No
1
2
802 Are there vaccines with VVM that reaches
discarding points (vaccine with 3rd or  4th
stages)?
Yes
No
1
2
If no
skip
to
804
803 List quantity of vaccines which have VVM
reaches discarding points (Vaccine with
VVM that reaches 3rd or 4th stages)
BCG _______
Measles _____
OPV ______
DPT-HepB-Hib ____
TT ______________
804 Do the health workers know how to read
VVMs?
Yes
No
1
2
805 Do the health workers use the information
on VVMs for vaccine management?
Yes
No
1
2
806 Are vaccines with VVMs used outside the
cold chain during outreach immunization
sessions?
Yes
No
1
2
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No. Question/Observation & filters Coding
Category
Current status/Findings
(observation findings)
Skip to
900 Multi Dose Vials Policy (MDVP) effectively in use
901 Are opened vials of freeze-dried
vaccines discarded at the end of
immunizations?
Yes
No
1
2
902 Are opened vials of liquid vaccine kept
for the next immunizations?
Yes
No
1
2
903 Can the health workers explain MDVP? Yes
No
1
2
1000 Vaccine wastage kept below satisfactory level
1001 Is there record for vaccine wastage for
all antigens?
Yes
No
1
2
1002 Do health worker know how to calculate
the wastage rate?
Yes
No
1
2
1003 Has the information available on the
vaccine wastage used to make others
changes? (worked to increase session
size, etc)
Yes
No
1
2
Injection safety
1100. Structural observations of equipment and supplies available at the health facility
I would like to start observing some of the equipment and supplies in this facility:
Total number of syringes available
(including those in sterilizer racks and those kept in the store)
Size/Type Disposable3 Auto-disable4 Cannot be assessed
1101 0.05 ml
1102 0.5 ml
1103 5 ml
1104 2 ml
1105 Presence of swabs used for skin
preparation that are dirt, bloodstained or
kept wet
1-
Yes
2-No Cannot
be assessed
1106 Number of punctured-proof safety
containers (safety boxes) in stock
0 1-4 5-9 10-20 =20
1107 Presence of safety boxes in areas where
injections are given
1-Yes 2-No
1108 Presence of overflowing, pierced, or open
sharp box (es)
1-Yes 2-No
1109 Number of full sharps box (es) waiting
for disposal/incinerations stored safely
Number
present
………………………
1110 Number of full sharps box (es) waiting
for disposal/incinerations stored in
unsupervised fashion
Number
present ……………………..
1111 Sharps in plastic bottles, or open 1-Yes 2-No
3 Number of disposable syringes and needles in sealed packets or fitted with 2 caps
4 Number of AD syringes and needles in sealed packets or fitted with 2 caps
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containers exposing staff to needle-stick
injuries
1112 Evidence of used sharps around the
health facility and/or the disposal site
1-Yes 2-No
1113 Type of waste disposal facility used for
the disposal of the majority of sharps
(circle only one)
1-Open burning on the ground
3- Incinerator
4- Dumping in pit or other secure pit
5- Transport for off-site treatment
2-Open burning in a
hole or an enclosure
6-Burial
7-Dumping in an
unsupervised area
1200. Structural observations of equipment and supplies available at the health facility
I would like to see you perform injections (immunizations): This section based up on observation
only
“Y” when yes,
“N” when no, “I”
if not applicable
1201 Preparation on a clean designated table or tray, where blood or body
fluid contamination is unlikely5
1202 Type of syringe used (1=AD, 2=disposable, 3= sterilizable)
1203 Did the client/care taker bring his/her syringe and needle for the
injection
1204 For each injection, use of syringe from sterile packs or fitted with 2
caps (disposable or AD syringes)6, or use of syringes that taken from
sterilizer using a sterile technique (sterilizable syringe)
1205 For each injection, use of need from sterile packs or fitted with 2 caps
(disposable or AD syringes), or use of syringes that taken from
sterilizer using a sterile technique (sterilizable syringe)
1206 Removal of all needles from the vaccine/medication vial between
injections
1207 (if glass ampoules are used) use of clean barrier (e.g. small gauze
pad) to protect fingers when breaking the top from the glass ampoules
1208 For each reconstitution, use of a sterile syringe and needle (from
sealed packet, fitted with 2 caps, or taken out of a sterilizer)
1209 (if vaccine) reconstitution of lyophilized vaccines with correct volume
of diluent from the same manufacturer
1210 (if other medication) reconstitution of powdered substances with
diluent a single-dose diluent vial
1211 (For heat sensitive vaccines and medictions only) vial kept between 20
C and 80 C during period of use.
1213 Two-hands re-capping of the needles after the injection (compared to
other items on the checklist, two-hands recapping is an undesirable
practice)
1214 (Disposable or AD syringes) collection in a puncture-proof safety
container immediately after the injection
5 Not an area also used for procedure that may lead to blood contamination (e.g. blood sampling, wound dressing
etc.)
6 If reuse of injection equipment is about to occur without sterilization, intervene to interrupt the procedure as
tactfully as possible and a “N” should be marked on the checklist.
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1300 Interview of injection provider7
I would like to ask you a few questions about how you give injections:
1301 How many injections are given per week on
average in your facility .......immunization/week ….. other
injection/week
Circle only one answer
1302 Do patient provide their own injection
equipment for immunizations?
1-
Always
2
sometimes
3-
never
4-
Don’t
know
1304 Do patient provide their own injection
equipment for therapeutic injections?
1-
Always
2
sometimes
3-
never
4-
Don’t
know
1305 Do you use needle remover or cutters before
disposing of injection equipment?
1-
Always
2
sometimes
3-never
1306 How many accidental needle-sticks have you
had in the last 12 months? ……………..accidental needle-sticks in
the last year
Policy and supplies
1307 Do you have a copy of the injection safety
policy/recommendations issued by your health
services?
1-
Always
2
sometimes
3-
never
4-
Don’t
know
1308 Do you have copy of the safe sharps and health
care waste disposal policy issued by your health
services?
For disposable or AD syringes
1309 In the last year, how long in total have
you been out of new, disposable or
AD syringes and needles?
Never < q
month
<3 month =3
month
4-
Don’t
know
1310 In the last year, how long in total you
been out of puncture proof sharps
containers?
Never < q
month
<3 month =3
month
4-
Don’t
know
1311 Are stocks of vaccines always
delved with matching quantity of
injection equipment?
1-Yes 2 No 3-Don’t
know
No
vaccination
here
1312 Are stocks of vaccines always
delved with matching quantity of
puncture proof sharp container?
1-Yes 2 No 3-Don’t
know
No
vaccination
here
Thank You very much for your time!!!
7 If more than one injection provider in the facility, select the one administering the largest number of injection
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2.0 Questioners
Immunization safety assessment study in health facilities of Addis Ababa
(Service Providers)
Questioner Identification:
001 Sub-city ----------------------------------- 002 Health facility name --------------------------------
003 Cluster No -------------------------------- 004 Record Number -------------------------------------
005 Name of Interviewer ---------------------006Date of interview __/___/___signature _________
007 Name of Supervisor ----------------------008 Date of interview __/___/___signature ______
Introduction and Consent
Verbal consent form
Good morning/afternoon. My name is ________________________________________.
Thank you for taking the time to talk with me. I came from Addis Continental Institute of
Public Health, a higher institution conducting Joint Master of Public Health (MPH) program
with the University of Gondar. We are asking questions of health workers /immunization
officers/ such as you, throughout Addis Ababa, and collecting data for a master's thesis named
“Assessment of routine immunization vaccines’ potency and injection safety study in
health facilities of Addis Ababa". This health center has been chosen to be included in the
study. If you agree to be interviewed, I will be asking you questions about your experience on
immunization safety, vaccines potency and injection safety. We are interested in finding out
what health workers think about immunization safety (vaccines’ potency and injection safety
that your facility is providing to child have). This information will be used to help quality
immunization services for children in Addis Ababa.
If you decide that you do not want to participate in the study, or decide at any time in the future
that you do not want to participate, it will not affect the services you receive at the health
center now or in the future. While the results of this study may be published, your privacy will
be protected and you will not be identified in any way. No one, including your service
provider, will know your answers.
Your opinions and experiences are important to us, so please be honest and truthful in
answering our questions. Your answers will be confidential and secret. If you agree to be
interviewed, we will go to a place where no one can hear us talking. If you are uncomfortable
with a question, you do not have to answer it if you do not want. You may also stop the
interview at any time.
It will take about 20-30 minutes for us to complete the questionnaire. Do you have any
questions about the study? If you have any questions about the study in the future, please feel
free to contact University of Gondar, Addis Continental Institute of Public Health and Addis
Ababa Health Bureau.
___________________________________         ____________
Signature of person administering consent            Date
If client refuses to be interviewed, please check this box:
Time interview began: _____:   ______
Hours    Minutes
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No. Questions & filters Coding
Category
Current status/Findings
(observation findings)
Skip to
100 Basic data
101 Respondent’s Sex 1
2
1. Male
2. Female
102 Respondent’s age (age in year)
103 Marital status 1
2
3
4
5
1. Single
2. Married
3. Widow
4. Separated
5. Divorced
104 Education/profession 1. Health Assistant
2. Junior Nurse
3. Senior  nurse
4. BSc nurse
5. Health Officer
6. Other ______
105 Unit/Section 1. EPI unit
2. Other ______
105 Service year in health profession ______ years
106 Service year in EPI ______ year
107 Since how long have you been giving
injection?
______ Record
by year
108 When and where did you learn to give
injections/ immunization?
1
2
3
4
5
1. during the formal
training
2. IIP training
3. Injection safety
training
4. Refresher training
5. Other (Specify)
___________________
More
than
one
respons
e s is
accepte
d
109 What type of injections you provide? 1
2
3
4
1. Immunization
2. Treatments
3. Diagnostic solutions
4. Other (specify)
110 How often do you provide
immunizations?
1
2
3
1. Daily
2. Occasionally when
staff  are absent
3. Other (specify)
Perceptions Regarding
Immunization/Injections
111 In your opinion, what is a safe
injection?
1 1. single sterile syringe and
needle for one
person/purpose/solutions
2. right
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2
3
4
5
6
7
medication/vaccine
3. right person
4. right site
5. no recapping
6. safe deposal using
safety box
7. proper waste disposal
methods and practices
112 Are there any risks associated with
injections?
Yes
No
1
2
113 If yes what are the possible risks 1. Infection with blood
born diseases (HIV,
HEP B and C) etc.
2. Injury
3. abscesses
4. Shock
5. Other specify
More
than
one
respons
e is OK
114 How common are such risks regarding
immunization in this area?
1. rare
2. some times
3. Often
4. Other (specify)
115 Do you ever get any complaints from
parents & pregnant women related to
immunization safety?
Yes
No
1
2
116 If yes, what types of complaints? 1.injury
2.abscess
3.infection with blood born
diseases (e.g Hep B
etc,)
117 Have you ever seen an abscess
following immunization?
Yes
No
1
2
118 How often have you seen abscesses? 1
2
3
4
1. rarely
2. usually
3. Often
4. Other
119 How do you communicate with
children, parents & pregnant women?
1
2
3
1. Through IEC session
2. while providing the
injection
3. Other
120 What do you do if have reconstituted
vaccines remained with considerable
doses (Measles with 8 doses or BCG
with 16 doses)?
1
2
3
4
1. return to cold chain
until next session
2. discard at the end of the
day
3. discard after 8 hours
4. discard after 6 hours
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121 What do you do if the power or the
refrigerator fails?
1
2
3
1. I will report to the next
level
2. I will move the vaccine
to the near by health
facility or kept it in the
cold box and report to
next level
3. do not know
122 What do you do if you find vaccine vial
that the level has removed?
1
2
3
4
1. I know very well the
vials by looking and
keep going using?
2. I will seek help from
colleagues to identify
the vaccine it contains
and keep going using
3. I will discard the vial
and note in the record?
4. I do know
Knowledge on Immunization
123 What is the standard temperature for
vaccine storage in the health facility
level?
1
2
3
4
1. 0-8 0c
2. 2-8 0c
3. > 0 and 8 0c
4. other ____
124 How frequent do measure the
temperature of your refrigerator?
1
2
3
4
1. daily once daily
2. twice daily
3. three times daily
4. other ____
125 Which vaccine needs shake test? 1
2
3
4
1. OPV
2. Measles
3. TT & DPT-HepB-Hib
4. BCG
126 Which vaccine need child water pack
when transported?
1
2
3
1. OPV
2. TT
3. TT & DPT-HepB-Hib
127 Can you list the cold chain monitoring
tools that often available in the health
facilities?
1
2
3
4
5
6
1. thermometer
2. freeze watch
3. VVM
4. data logger
5. All
6. other _____
128 Which VVM stages required discarding 1
2
3
4
1. Stage three with
expired date not
passed
2. stage one with
expire date already
passed
3. Stage 4 with expired
date not passed
4. Other
129 What is multi dose vial policy (MDVP)? 1 1. keep all opened
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2
3
4
vaccine after wrap-
up immunization for
next session
2. Discarded all open
vials at the end of
the session
3. Return opened vials
which have good
VVM status for next
session
4. Other _____
130 Which vaccines are treated with Multi
dose open vial policy (MDVP)?
1
2
3
4
1. OPV
2. Measles
3. TT and DPT
4. BCG
131 Which types of the hepatitis are
transmitted through unsafe injection?
1
2
3
4
5. Hepatitis A
6. Hepatitis B
7. Hepatitis C
8. Other
132 How can it be prevented? 1
2
3
4
5
1. IEC
2. Injection safety
measures
3. Vaccines
4. Behavioral changes
5. Other if any
133 What do you do if you have more
children awaited for vaccines and if you
do not have syringes?
1
2
3
4
1. use regular
disposable syringes
2. give appointment for
next day and collect
supplies
3. use re-sterilized
regular syringes and
needles
4. Other
Thank You for your time!!
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3.0 Questioner:
Assessment of Vaccines’ potency and injection safety practices
In health facilities of Addis Ababa
Mothers Having Children who have taken vaccine 4-8 weeks prior to the survey date
Questioner Identification:
001 Sub-city ----------------------------------- 002 Health facility name ---------------------------------
003 Cluster No -------------------------------- 004 Record Number --------------------------------------
005 Name of Interviewer ---------------------006Date of interview __/___/___signature _________
007 Name of Supervisor ----------------------008 Date of interview __/___/___signature ________
Introduction and Consent
Verbal consent form
Good morning/afternoon. My name is ________________________________________.
Thank you for taking the time to talk with me. I came from Addis Continental Institute of Public
Health, a higher institution conducting Joint Master of Public Health (MPH) program with the
University of Gondar. We are asking questions of care takers/parents such as you, throughout Addis
Ababa, and collecting data for a master's thesis named “Routine immunization vaccines’ potency and
injection safety assessment study in health facilities of Addis Ababa". This health center has been
chosen to be included in the study. If you agree to be interviewed, I will be asking you questions about
your child immunization status, vaccines potency and injection We are interested in finding out what
caretakers/parents think about immunization safety (vaccines’ potency and injection safety that your
child have received. This information will be used to help quality immunization services for children in
Addis Ababa.
If you decide that you do not want to participate in the study, or decide at any time in the future that you
do not want to participate, it will not affect the services you receive at the health center now or in the
future. While the results of this study may be published, your privacy will be protected and you will not
be identified in any way. No one, including your service provider, will know your answers.
Your opinions and experiences are important to us, so please be honest and truthful in answering our
questions. Your answers will be confidential and secret. If you agree to be interviewed, we will go to a
place where no one can hear us talking. If you are uncomfortable with a question, you do not have to
answer it if you do not want. You may also stop the interview at any time.
It will take about 20-30 minutes for us to complete the questionnaire. Do you have any questions about
the study? If you have any questions about the study in the future, please feel free to contact University
of Gondar, Addis Continental Institute of Public Health and Addis Ababa Health Bureau.
___________________________________         ____________
Signature of person administering consent            Date
If client refuses to be interviewed, please check this box:
Time interview began: _____:   ______
Hours    Minutes
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No. Questions & filters Current status/Findings
(observation findings)
Coding
Catego
ry
Skip to
100 Perceptions Regarding Immunization
101 Respondents Sex 1. Male
2. Female
102 Respondents age (age in year)
103 Marital status 1. Single
2. Married
3. Widow
4. Separated
5. Divorced
104 Education 1.can not read and write
2.1-6 grade
3.7-10 grade
4.11-12 grade
5.Collage and above
105 Occupation
106 Family monthly income
107 Relation to the child 1. mother
2. Father
3. Sister
4. Guardian
5. grandmother
6. Other ______
108 Child’ age in month
109 Child’s immunization status 1. BCG & OPV 0
2. OPV1 & Penta 1
3. OPV 2 & Penta 2
4. OPV 3 & Penta 3
5. Measles
Knowledge and attitude about immunization
110 Is it important to immunize children? 1. yes
2. No
111 What is the benefit of immunizing
children/
1. prevent diseases
2. prevent from measles
3. prevent from polio
4. other
More than one
responses
112 Do you know the type of vaccines
provided in this health facility?
1. Yes
2. No
If no skip to 116
113 If yes ,please list them 1. Measles
2. BCG
3. Pertusis
4. Diphtheria
5. Tetanus
6. Hep B
7.Hemophilus influenza B
8. Polio
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9. other
114 Do you know about the safety
measures that protects vaccines’
potency and safety
1. Yes
2. No
115 If yes, what are these safety measures? 1.maintaining standard
temperature
2. check the expiry date
3. other
116 Who motivated/encouraged you to
immunize your children?
1. the health workers
2. neighbors
3. family members
4. Kebele
5. Media (Radio, TV)
6. Other specify
_____________________
_____________________
_____________________
___
More than one
responses
117 What interaction do you have with
health workers (nurses, HEWs etc)
regarding immunization?
1. exchange information
about EPI diseases
2. exchange information
about next doses
3. exchange information
about AEFI
4. Other specify
More than one
responses
118 What is the attitude of local people
regarding immunization?
1. Positive
2. Negative
3. I don’t know
119 Which of the vaccines are injectable? 1. Measles
2. Tuberculosis
3.. pertusis
4.Diphtheria
5. Tetanus
6. Hepatitis B
7. Hemophilues influenza
type b
8. Polio
9. Other (specify)
More than one
responses
120 What is an unsafe injection? 1. using un-sterile
injection devices
2. using disposable
syringes
3. sharing syringes
and needles
4. injecting in the
wrong site
5. Administering
wrong medication
More than one
responses
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6. Other (Specify)
_____________________
_____________________
_____________
121 What types of risks are associated with
unsafe injections?
1.infections with HIV
2. Infection with Hepatitis
3. injury
4. Injection abscess
5. Other (specify)
_____________________
_____________________
_____________________
_____________________
122 Have you seen/heard about unsafe
injections?
1.Yes
2.No
123 If yes when?
124 Where?
125 Please describe to me the situation
126 What will happens to syringes, needles
and other materials after they have
been used /discarded at the
immunization places?
1. Put in to the boxes
and buried/burned
2. Put in to buckets
3. Put in to table
4. put in to any
available container
(other than the
above)
5. put  in to the floor
6. Other (specify)
_____________________
_____________________
_____________________
_____________________
127 Did your child ever develop abscess
after received injectiable vaccine?
1.Yes
2.No
128 If yes when was it?
129 What did you do? 1. Consult the health
workers
2. took him/her to
traditional heeler
3. healed by itself
4. Home care given
by house hold
5. Other (Specify)
_____________________
_____________________
___
Thank You very much for your time!!!
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4.00
¾¡ƒvƒ SÉH’>„‹ ÅI”’ƒ ›Övup “ uS`ô ¾T>cØ ¡ƒvƒ /SÉH’>ƒ ÅI”’ƒ/
Ø”no G<’@ Ø“ƒ
u›Kñƒ Ÿ4 eŸ 8 dU” ƒ ¨<eØ ¡ƒvƒ ¾¨cÆ Ií“ƒ ¨LÐ‹ ¨ÃU ›dÇÑ>­‹
¾°¨<kƒ “ ¾Ó”³u? SKŸ=Á SÖÃp
uØ“~ KSd}õ ¾eUU’ƒ T[ÒÑÝ
Ö?“ ÃeØM˜ ’@ vLKG< K=Á’ÒÓ\˜ ðnÅ— uSJ•
›ScÓ“KG< ¾S×G<ƒ ›Ç=e ¢”+’@” M ¾Iw[}cw Ö?“ ƒUI`ƒ }sU c=J” }sS<
ŸÑA”Å` Ä’>y`c=+ Ò` uIw[}cw Ö?“ ƒUI`ƒ ¾ÉI[ U[n ƒUI`ƒ Ãc×M::
KÉI[ U[n ƒUI`ƒ ›"M ¾J’ Ø“ƒ ¾¡ƒvƒ SÉH’>„‹ ÅI”’ƒ ›Övup “
uS`ô ¾T>cØ ¡ƒvƒ /SÉH’>ƒ  ÅI”’ƒ/ Ø”no uT>M `°e ÁŸ=ÁH@É” ’¨<::
u²=G< SW[ƒ M¡ ”Å`f u›Ç=e ›uv K¡ƒvƒ ›ÑMÓKAƒ ¾T>SÖ< ¨LÐ‹”
eKMÐ‰†¨< ¾¡ƒvƒ G<’@ ”Ç=G<U eK¡ƒvƒ SÉH’>ƒ ÅI”’ƒ ›Övup “ eKS`ô
›ÑMÓKAƒ Ø”no u}SKŸ} ØÁo­‹” Ák[w” ’¨<:: ¾Ø“~ ›LT
¨LÐ‹/›dÇÑ>­‹ MÐ‰†¨< eKT>Ÿ}u<ƒ ¡ƒvƒ 'eK¡ƒv„‡ ÅI”’ƒ “  uS`ô
eKT>cØ ¡ƒvƒ/SÉH’>ƒ Ø”no T¨p c=J” ¾Ø“~U ¨<Ö?ƒ u›Ç=e ›uv
¾T>cÖ¨<” ¾¡}vƒ ›ÑMÓKAƒ Ø^ƒ KThhM Ã[ÇM::
¾Ø“~ ¨<Ö?ƒ U“Mvƒ ¨Åòƒ u= }U `f uØ“~ eKSd}ö­ ueUU J’
uT“†¨<U G<’@ ¾TÃÑKê c=J” ›ÑMÓKAƒ ¾T>cØ­ƒ vKS<Á ¾T>cÖ<ƒ” SMf‹
›Á¿ƒU:: uØ“~ Sd}õ "MðKÑ< ¨ÃU u¨<ÃÃ~ ¨pƒ KTs[Ø u=ðMÑ< uÖ?“
É`Ï~ ¾T>cÖ¨<” ›ÑMÓKAƒ ›G<”U J’ ¨Åòƒ ›ÁcÙ­ƒU::
KSd}õ ðnÅ— ŸJ’< ¾`f ›SK"Ÿƒ Ó”³u? KØ“~ u×U ›eðLÑ> eKJ’ ØÁo­‹
SMe c=cÖ< ÓMî “ ¨<’}— ”Ç=J’<M” ”ÖÃnK”:: ŸLÃ ”Å}ÑKì¨< ¾T>cÖ<ƒ
SMe T>eØ`’ƒ ¾}Öuk ’¨<::
u¨<ÃÃ ‹” ¨pƒ KSSKe ÁMðKÑ<ª†¨<” ØÁo­‹ K=}ª†¨< Ã‹LK<:: uðKÑ<
Ñ>²?U ¨<ÃÃ~” K=Ás`Ö< Ã‹LK<::
u¨<ÃÃ †” ¨pƒU K?KA‹ c­‹ ”ÇÁ¨<Ÿ<”“ ¨<ÃÃ ‹” ”ÇÁÇUÖ< ìØ ¨ÇK
ØÓ/eõ^ ”H>É:: ØÁo­‡” uS<K< KSSKe ¾T>ðË¨< Ñ>²? Ÿ20 - 30 Åmn
ÃJ“M::
eKØ“~ ØÁo ›M­; ¨ÅòƒU eKØ“~ ØÁo­‹ "M­ ›Ç=e ¢”+’@” M ¾Iw[}cw
Ö?“ ƒUI`ƒ }sU” ¨ÃU ›Ç=e ›uv ¾Ö?“ u=a” ”Ç=G<U ÑA”Å` Ä’>y`c=+
¾I¡U“ ƒUI`ƒ ¡õM T’ÒÑ` Ã‹LK<::
¾eUS’ƒ ØÁo ›p^u= ò`T k”
ØÁo¨<” KSSKe Ÿ}n¨S< uòKòƒ dØ” UM¡ƒ ›É`Ó
¨<ÃÃƒ ¾}ËS[uƒ c›ƒ :
c›ƒ  Åmn
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¾SÖÃl SKÁ
001 ¡/Ÿ}T 002 ¾Ö?“ }sU
003 ]Ÿ`É SKÁ 004 ¾ØÁo ›p^u=¨< eU
005 SÖÃl ¾}VLuƒ k” 006 ò`T
007 ¾}q××]¨< eU 008 k” ò`T
}.l SÖÃp ›T^ß SMf‹ ¢É SÓKÝ
100 TIu^© “ ›=¢•T>Á© S[Í
101 ¾SMe cÜ¨< ï 1. ¨”É
2. c?ƒ
102 ¾SMe cÜ¨< ÉT@
103 ¾Òw‰ G<’@ 1. ÁLÑv‹/v
2. vKƒÇ`
3. vMª/T>e~ ¾V}‹uƒ
4. ¾}KÁ¿
5. ðƒ
6. K?L ÃÑKê
104 ¾ƒUI`ƒ Å[Í 1. T”uw “ Síõ ¾TÃ‹K<
2. T”uw “ Síõ ¾T>‹K<
3. 1-6 ¡õM
4. 7-10 ¡õM
5. 11- 12 ¡õM
6. ¢K?Ï “ Ÿ³ uLÃ
7. K?L ÃÑKê
105 E^
106 ¾u?}cw ¾¨` Ñu=
107 Ÿ}Ÿ u=¨< Ií” Ò` ÁK ´UÉ“ 1. “ƒ
2. ›vƒ
3. Iƒ
4. ›dÇÑ>
5. ›Áƒ
6. K?L ÃÑKê
108 ¾Ií’< °ÉT@ u¨`
109 ¾Ií’< ¾¡ƒvƒ G<’@ (SÖÃl
u}Å[Ñuƒ k” ¾¨cÅ¨<)
1. u=c=Í= “ þK=Ä ²=a ¾¨cÅ
2. þK=Ä “ ü” 1 ¾¨cÅ
3. þK=Ä “ ü” 2 ¾¨cÅ
4. þK=Ä “ ü” 3 ¾¨cÅ
5. ¾Ÿ<õ˜ SŸLŸÁ ¾¨cÅ
eK ¡ƒvƒ °¨<kƒ/Ó”³u?“ ›SK"Ÿƒ
110 Ií“ƒ” TeŸ}w ÃÖpTM; 1. ›­
2. ›Ã
111 Ií“ƒ” TeŸ}w KU”
ÃÖpTM;
1. ui ” ÃŸLŸLM
2. Ÿ<õ˜” ÃŸLŸLM
3. þK=Ä” ÃŸLŸLM
4. K?L ÃÑKî
¾T>cÖ<ƒ
”
SMf‹
G<K<
UM¡ƒ
›É`Ó
112 U²=I Ö?“ É`Ïƒ  ¾T>cÖ<ƒ
¾¡ƒvƒ ›Ã’„‹ ¾ƒ™‡
”ÅJ’< Á¨<nK<
1. ›­
2. ›Ã
¾cÖ<ƒ
SMe
›Ã ŸJ’
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¨ÅØÁo
116 ´KM
113 "¨l Ã²`´\M˜ (¾ƒ™‡
“†¨<)
1. ¾Ÿ<õ˜ SŸLŸÁ
2. ¾d”v ’k`d SŸLŸÁ
3. ¾ƒ¡ƒ¡ SŸLŸÁ
4. ¾²Ñ>›“Ç SŸLŸÁ
5. ¾S”ÒÒ qMõ
6. ¾Ñ<uƒ ui SŸLŸÁ
7. ¾›=”õKA«”³ SŸLŸÁ
8. ¾þK=Ä SŸLŸÁ
9. K?L ÃÑKî
¾T>cÖ<ƒ
”
SMf‹
G<K<
UM¡ƒ
›É`Ó
114 ŸLÃ ¾}ÑKì<ƒ ¡ƒv„‹”
ÅI”’ƒ “ õ~I’ƒ KSÖup
eKT>Å[Ñ< Ø”no­‹ Á¨<nK<;
1. ›­
2. ›Ã
115 "¨l Ø”no­‡ U”É”
“†¨<;
1. u}SÅuL†¨< ¾p´n²?
SÖ” uTk´k¹ ¨<eØ
TekSØ
2. ¾›ÑMÓKAƒ Ñ>²?Á†¨<
›KTKñ” T[ÒÑØ
3. K?L "K ÃÑKî
116 MÐ” ”Ç=ÁeŸƒu< U”
›’dd­ƒ/›u[ ­;
1. Ö?“ vKS<Á
2. ÑA[u?ƒ
3. Ÿu?}cw ›vM
4. ŸkuK?
5. Ÿ_ÉÄ/‚K?{»”
6. K?L ÃÑKî
¾T>cÖ<ƒ
”
SMf‹
G<K<
UM¡ƒ
›É`Ó
117 ¡ƒvƒ” u}SKŸ} ŸÖ?“
vKS<Á­‹ Ò` (’[e ¨²})
U” ›Ã’ƒ ¨<ÃÃƒ ÁÅ`ÒK<
1. eK¡ƒvƒ S[Í­‹
SKª¨Ø
2. eKT>kØK¨< ¾¡ƒvƒ
›Ã’ƒ “ Ñ>²? S[Í ›Ñ—KG<
3. ¡ƒvƒ” }ŸƒK¨<
eKT>SÖ< G<’@ ­‹
SÓKÝ/ƒUI`ƒ
4. K?L ÃÑKî
¾T>cÖ<ƒ
”
SMf‹
G<K<
UM¡ƒ
›É`Ó
118 ÉT@›†¨< Ÿ›Ueƒ ›Sƒ u ‹
¾J’ Ií“ƒ uu?ƒ­ ›K<;
(K¡ƒvƒ ŸS×¨< Ií” K?L)
1. ›­
2. ›Ã
¾cÖ<ƒ
SMe
›Ã ŸJ’
¨Å ØÁo
121 ´KM
119 G<K<U Ií“ƒ ¾SËS]Á
MÅ †¨< ŸT¡u^†¨< uòƒ
G<K<”U ¡ƒvƒ }Ÿƒuª;
1. ›­
2. ›Ã
120 "M}Ÿ}u< KU”; (ŸLÃ SMe
ŸcÖ<v†¨< MÐ‹ ›”Æ ¨ÃU
Ÿ²=Á uLÃ "M}Ÿ}u<)
1. eK¡ƒvƒ ØpU ›L¨<pU
’u`
2. ¡ƒvƒ ÁeðMÒ†¨< ”Å’u`
›L¨<pU ’u`
3. u¡ƒvƒ ›LU”U ’u`
4. K?L "K ÃÑKê
121 ¾›"vu=¨< ’ª] eK ¡ƒvƒ
ÁK¨< ›SK"Ÿƒ U”É” ’¨<;
1. Ø\ ’¨<
2. ›K< © ’¨<
3. ›L¨<pU
eK uS`ô eKT>cØ ¾¡ƒvƒ ›ÑMÓKAƒ ÅI”’ƒ/Ø”no °¨<kƒ “ Ó”³u? SÖÃp
122 uS`ô ¾T>cÖ<ƒ ¾¡ƒvƒ 1. ¾Ÿ<õ˜ SŸLŸÁ ¾T>cÖ<ƒ
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›Ã’„‹ ¾ƒ™‡ “†¨<; 2. ¾d”v ’k`d SŸLŸÁ
3. ¾ƒ¡ƒ¡ SŸLŸÁ
4. ¾²Ñ>›“Ç SŸLŸÁ
5. ¾S”ÒÒ qMõ
6. ¾Ñ<uƒ ui SŸLŸÁ
7. ¾›=”õKA«”³ SŸLŸÁ
8. ¾þK=Ä SŸLŸÁ
9. K?L ÃÑKî
”
SMf‹
G<K<
UM¡ƒ
›É`Ó
123 eK Ñ<uƒ ui (›Ã”” u=Ý
¾T>ÁÅ`Ó ui ) Á¨<nK<;
1. ›­
2. ›Ã
¾cÖ<ƒ
SMe
›Ã ŸJ’
¨Å ØÁo
126 ´KM
124 "¨l ¾ui ¨< UM¡„‹ U”É”
“†¨<;
1. ›Ã”” u=Ý ÁÅ`ÒM
2. Ñ<uƒ” ÁÖnM
3. K?L ÃÑKî
125 ”Èƒ Ã}LKóM 1. uÅU ”Ÿ=Ÿ= (uui ¨<
¾}Á²¨< c¨< ÅU)
2. uui ¨< ¾}uŸK eKƒ
uSÖkU
3. u›”É S`ô uÒ^ SÖkU
4. uui ¨< Ÿ}Ön c¨< Ò`
¾Ów[ eÒ Ó”–<’ƒ TÉ[Ó
5. Ÿ “ƒ ¨Å ê”e
6. K?L ÃÑKî
¾T>cÖ<ƒ
”
SMf‹
G<K<
UM¡ƒ
›É`Ó
126 ”Èƒ SŸLŸM Ã‰LM 1. ”îI“¨< ¾}Öuk S`ô
SÖkU (›”É S`ô K›”É
c¨<)
2. ¾ÅU ”Ÿ=Ÿ=” Te¨ÑÉ
3. ¡ƒvƒ
4. ¾vI] K¨<Ø
5. K?L ÃÑKî
¾T>cÖ<ƒ
”
SMf‹
G<K<
UM¡ƒ
›É`Ó
127 ƒ¡¡K— ÁMJ’ (›ÅÑ—) ¾S`ô
›ÑMÓKAƒ U”É” ’¨<;
1. ”îI“¨< ÁM}Öuk S`ô
“ e]”Ï SÖkU
2. K›”É Ñ>²? ¾T>ÁÑKÓM
e]”Ï “ S`ô” SÖkU
3. S`ô “ e]”Ï uÒ^
SÖkU
4. ƒ¡¡K— vMJ’ x /¾c¨<’ƒ
¡õM S¨Òƒ/
5. ¾}dd} SÉH’>ƒ S¨Òƒ
6. K?L "K ÃÑKî
¾T>cÖ<ƒ
”
SMf‹
G<K<
UM¡ƒ
›É`Ó
128 ƒ¡¡K— ÁMJ’ (›ÅÑ—) uS`ô
›ÑMÓKAƒ SÖkU U” eÒ„‹
›K<ƒ;
1. K›?‹ ›Ã y= ›?Ée
ÁÒM×M
2. KÑ<uƒ ui ÁÒM×M
3. uc¨<’ƒ LÃ ›ÅÒ ÁeŸƒLM
4. SÉH’>~ u}cÖuƒ eõ^
wÖƒ “ leM ÁeŸƒLM
5. K?L "K ÃÑKê
¾T>cÖ<ƒ
”
SMf‹
UM¡ƒ
›É`Ó
129 ƒ¡¡K— ÁMJ’ (›ÅÑ—) uS`ô
¾T>WØ ›ÑMÓKAƒ ›ÒØVM
1. ›­
2. ›Ã
71
(›Ã}ªM)
130 "ÒÖU­ƒ SŠ;
131 ¾ƒ;
132 G<’@ ¨<” u=Áw^\M˜;
133 U¡ƒvƒ SeÝ ¡õM S`ô“
e]”Ï ØpU LÃ ŸªK< u L U”
ÃÅ[ÒK<;
1. u}²ÒËL†¨< "`„” ¨<eØ
ÃÚS^K<
2. uvK= ¨<eØ Ã¨[¨^M
3. uÖ[â?³LÃ ÃkS×K<
4. u}Ñ–¨< TekSÝ
ÃŸT‰K<
5. u¨KM LÃ Ã×LK<
6. K?L "K ÃÑKî
134 MÏ­ uS`ô ¾T>cØ ¡ƒvƒ
Ÿ¨cÅ u L ¡ƒvƒ u¨cÅuƒ
ß’<LÃ ¨²} wÖƒ ›ÒØVƒ
Á¨<nM
1. ›­
2. ›Ã
135 SŠ;
136 U” ›Å[Ñ<; 1. ¾Ö?“ vKS<Á ›TŸ`Ÿ<˜
2. ¾vIM I¡U“ SeÝ ×u=Á
¨cÉŸ<
3. u^c< Ç’
4. u?ƒ ¨<eØ }”ŸvŸw’¨<
5. K?L "K ÃÑKê
Ñ>²?­” ¨eÅ¨< ¾Ø“~ }d ò eKJ’< ›ScÓ“KG<::
